Disease/Infection News

RSS

Gilead Sciences to present Viread Phase III clinical trial data

Gilead Sciences, Inc. today announced the presentation of three-year (144-week) open label data from two pivotal Phase III clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection.

2 Nov 2009

Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study

Optimer Pharmaceuticals, Inc. today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.

2 Nov 2009

MRSA bloodstream infection linked to high mortality rate

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.

2 Nov 2009

Response and investigation of the outbreak of foodborne illnesses vary greatly

A survey of state health departments regarding their capacity to track produce-related foodborne illnesses found that the response and investigation of outbreaks varies greatly and can lead to delays in public-health response.

31 Oct 2009

RESPOND program to improve global perspective on emerging diseases

Experts from the University of Minnesota will soon be on the frontlines working to help developing countries better respond to emerging animal diseases that pose a threat to human health.

31 Oct 2009

AHF praises Obama for lifting travel ban on HIV-infected people

AIDS Healthcare Foundation (AHF) today lauded President Barack Obama for lifting a 22 year-old ban prohibiting HIV-positive foreigners from traveling to the US. The US was one of only twelve countries with such a travel ban. Obama announced repeal of the ban after signing the legislation renewing the Ryan White CARE Act, the federal law that authorizes the primary source of funding for AIDS care and services nationwide.

31 Oct 2009

Scientists report a major step forward in the development of an effective therapy against Nipah virus

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

31 Oct 2009

GAA welcomes Obama's announcement to lift HIV travel ban

The Global AIDS Alliance welcomes President Obama's announcement today to lift the 22 year-old U.S. travel and immigration ban on those living with HIV/AIDS. GAA Executive Director Paul Zeitz said "We congratulate President Obama on his decision to end this unfounded and discriminatory policy. This is an important sign of U.S. leadership and commitment."

31 Oct 2009

Canada's doctors thank government for easing sick note requirements during H1N1 pandemic

Canadian Medical Association President Dr. Anne Doig commended the federal government today for easing its requirements for sick notes during the H1N1 pandemic.

31 Oct 2009

New tools and interventions can help in eradicating malaria

Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year.

31 Oct 2009

Four abstracts on RSV and influenza prevention in pediatric health to be presented

MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.

31 Oct 2009

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Patients who acquire skin and soft tissue infections (SSTIs) in a hospital or other healthcare setting may be more likely to receive inappropriate antibiotic therapy at the beginning of their treatment. As a result, they also may have significantly longer hospital stays to control the infection.

31 Oct 2009

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses.

31 Oct 2009

Speaker Pelosi's statement on signing of the Ryan White HIV/AIDS Treatment Extension Act

Speaker Nancy Pelosi issued the following statement today after attending a ceremony at the White House where President Obama signed the Ryan White HIV/AIDS Treatment Extension Act into law.

31 Oct 2009

Requests to compound liquid Tamiflu have steadily increased over the past couple of weeks

There has been a lot of information about the importance of taking preventative measures against H1N1, primarily through vaccination. But what if a person has already contracted H1N1? What if that person is a young child?

31 Oct 2009

Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART

Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+™ delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).

31 Oct 2009

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.

31 Oct 2009

MedImpact to provide a suite of free, online flu self-assessment tools

MedImpact has collaborated with the American Medical Association (AMA) and other health care organizations to provide a suite of free, online flu self-assessment tools to MedImpact clients and to the 32 million individual members they serve.

31 Oct 2009

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

Tufts University has been tapped by the United States Agency for International Development (USAID) as part of a multidisciplinary team that will receive a grant of up to $185-million to create better synergies among veterinarians, doctors, and public health officials in responding to emerging infectious diseases.

31 Oct 2009

Women may need smaller dose of H1N1 vaccine

THE emergence of the H1N1 swine flu has added urgency to what has become an annual ritual for millions of Americans: getting a flu shot. The good news is that scientists have developed a vaccine against the H1N1 virus. But it is taking much longer than expected to produce the hundreds of millions of doses the government had planned to distribute. And it is still too soon to know how effective the vaccine will be in preventing swine flu.

31 Oct 2009

Disease/Infection News

Gilead Sciences to present Viread Phase III clinical trial data

Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study

MRSA bloodstream infection linked to high mortality rate

Response and investigation of the outbreak of foodborne illnesses vary greatly

RESPOND program to improve global perspective on emerging diseases

AHF praises Obama for lifting travel ban on HIV-infected people

Scientists report a major step forward in the development of an effective therapy against Nipah virus

GAA welcomes Obama's announcement to lift HIV travel ban

Canada's doctors thank government for easing sick note requirements during H1N1 pandemic

New tools and interventions can help in eradicating malaria

Four abstracts on RSV and influenza prevention in pediatric health to be presented

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

Speaker Pelosi's statement on signing of the Ryan White HIV/AIDS Treatment Extension Act

Requests to compound liquid Tamiflu have steadily increased over the past couple of weeks

Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

MedImpact to provide a suite of free, online flu self-assessment tools

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

Women may need smaller dose of H1N1 vaccine

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News